Health economic controversy and cost-effectiveness of proton therapy

Seminars in Radiation Oncology

Volumn 23, Issue 2, 2013, Pages 134-141

  Lievens, Yolande ^a   Pijls Johannesma, Madelon ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER MODEL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; DATA ANALYSIS; FUNDING; HEALTH CARE; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; METHODOLOGY; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTON THERAPY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RADIOTHERAPY; REGISTER; SYSTEMATIC ERROR; TECHNOLOGY;

COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; HEALTH CARE COSTS; HUMANS; MODELS, ECONOMIC; NEOPLASMS; PROTON THERAPY; RADIATION ONCOLOGY;

EID: 84875259231     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2012.11.005     Document Type: Article

References (47)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
2. Bodenheimer T. High and rising health care costs. Part 2: Technologic innovation. Ann Intern Med 2005, 142:932-937.
3. Detsky A.S., Naglie I.G. A clinician's guide to cost-effectiveness analysis. Ann Intern Med 1990, 113:147-154.
4. Drummond M., McGuire A. Economic Evaluation in Health Care: merging theory with practice 2006, 286. Oxford University Press, Oxford.
5. Cleemput I., Neyt M., Thiry N., et al. Threshold Values for Cost-Effectiveness in Health Care. Brussels, KCE reports 2008, 100C.
6. Sensible and sustainable care [in Dutch] 2006, Council-for-Public-Health-and-Health-Care, Council for Public Health and Health Care, Zoetermeer, The Netherlands.
7. Pijls-Johannesma M., Pommier P., Lievens Y. Cost-effectiveness of particle therapy: Current evidence and future needs [Review]. Radiother Oncol 2008, 89:127-134.
8. Brada M., Pijls-Johannesma M., De Ruysscher D. Proton therapy in clinical practice: Current clinical evidence. J Clin Oncol 2007, 25:965-970.
9. Brada M., Pijls-Johannesma M., De Ruysscher D. Current clinical evidence for proton therapy. Cancer J 2009, 15:319-324.
10. Lodge M., Pijls-Johannesma M., Stirk L., et al. A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiother Oncol 2007, 83:110-122.
11. Olsen D.R., Bruland O.S., Frykholm G., et al. Proton therapy-A systematic review of clinical effectiveness. Radiother Oncol 2007, 83:123-132.
12. De Ruysscher D., Mark Lodge M., Jones B., et al. Charged particles in radiotherapy: A 5-year update of a systematic review. Radiother Oncol 2012, 103:5-7.
13. van de Water T.A., Bijl H.P., Schilstra C., et al. The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: A systematic review of literature. Oncologist 2011, 16:366-377.
14. Roelofs E., Engelsman M., Rasch C., et al. Results of a multicentric in silico clinical trial (ROCOCO): Comparing radiotherapy with photons and protons for non-small cell lung cancer. J Thorac Oncol 2011, 7:165-176.
15. Roelofs E., Persoon L., Qamhiyeh S., et al. Design of and technical challenges involved in a framework for multicentric radiotherapy treatment planning studies. Radiother Oncol 2010, 97:567-571.
16. Ploquin N.P., Dunscombe P.B. The cost of radiation therapy. Radiother Oncol 2008, 86:217-223.
17. Glatstein E., Glick J., Kaiser L., et al. Should randomized clinical trials be required for proton radiotherapy? An alternative views. J Clin Oncol 2008, 26:2438-2439.
18. Glimelius B., Montelius A. Proton beam therapy-Do we need the randomised trials and can we do them?. Radiother Oncol 2007, 83:105-109.
19. Goitein M. Magical protons?. Int J Radiat Oncol Biol Phys 2008, 70:654-656.
20. Goitein M., Cox J.D. Should randomized clinical trials be required for proton radiotherapy?. J Clin Oncol 2008, 26:175-176.
21. Lewis B.E. On equipoise and emerging technologies. J Clin Oncol 2008, 26:2590. , author reply: 2593-2596.
22. Macbeth F.R., Williams M.V. Proton therapy should be tested in randomized trials. J Clin Oncol 2008, 26:2590-2591. author reply: 2593-2596.
23. Morgan J.P. A patient's perspective on randomized clinical trials for proton radiotherapy. J Clin Oncol 2008, 26:2592. author reply: 2592-2593.
24. Suit H., Kooy H., Trofimov A., et al. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiother Oncol 2008, 86:148-153.
25. Willan A.R. Incremental net benefit in the analysis of economic data from clinical trials, with application to the CADET-Hp trial. Eur J Gastroenterol Hepatol 2004, 16:543-549.
26. Claxton K., Sculpher M., Drummond M. A rational framework for decision making by the national institute for clinical excellence (NICE). Lancet 2002, 360:711-715.
27. Briggs A., Sculpher M., Claxton K. Decision Modelling for Health Economic Evaluation 2006, Oxford University Press, Oxford.
28. Grutters J.P., Pijls-Johannesma M., Ruysscher D.D., et al. The cost-effectiveness of particle therapy in non-small cell lung cancer: Exploring decision uncertainty and areas for future research. Cancer Treat Rev 2010, 36:468-476.
29. Corazza U., Filippini R., Setola R. Discrete event simulation of a proton therapy facility: A case study. Comput Methods Programs Biomed 2011, 102:305-316.
30. Goitein M., Jermann M. The relative costs of proton and X-ray radiation therapy. Clin Oncol R Coll Radiol 2003, 15:S37-S50.
31. Peeters A., Grutters J.P., Pijls-Johannesma M., et al. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons. Radiother Oncol 2010, 95:45-53.
32. Oncology_Roundtable. 2012 Medicare Reimbursement Update. Webconference, January 10, 2012. Available at: http://www.advisory.com/Research/OncologyRoundtable/Events/Webconferences/2011/%7E/media/Advisory-com/Research/OR/Events/Webconference/2011/2012-Reimbursement-Updated-FINAL_OR.pdf.
33. Dvorak T., Wazer D.E. Evaluation of potential proton therapy utilization in a market-based environment. J Am Coll Radiol 2010, 7:522-528.
34. Weinstein M.C., Siegel J.E., Gold M.R., et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996, 276:1253-1258.
35. Konski A., Bhargavan M., Owen J., et al. Feasibility of economic analysis of radiation Therapy Oncology Group (RTOG) 91-11 using Medicare data. Int J Radiat Oncol Biol Phys 2011, 79:436-442.
36. Van de Werf E., Verstraete J., Lievens Y. The cost of radiotherapy in a decade of technology evolution. Radiother Oncol 2012, 102:148-153.
37. Van de Werf E., Lievens Y., Verstraete J., et al. Time and motion study of radiotherapy delivery: Economic burden of increased quality assurance and IMRT. Radiother Oncol 2009, 93:137-140.
38. Perrier L., Combs S., Auberger T., et al. A decision-making tool for a costly innovative technology: The case of carbon ion radiotherapy. J Econ Méd 2007, 25:367-380.
39. Pommier P., Gueye N., Buron C., et al. Medico-economic and spatial modelization for decision making in innovative therapies: Application to light ions therapy projects in Europe. Radiother Oncol 2006, 81:S411.
40. Baker J.J. Activity-Based Costing and Activity-Based Management for Healthcare 1998, Aspen Publishers, Gaithersburg.
41. Konski A., Speier W., Hanlon A., et al. Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate?. J Clin Oncol 2007, 25:3603-3608.
42. Lundkvist J., Ekman M., Ericsson S.R., et al. Economic evaluation of proton radiation therapy in the treatment of breast cancer. Radiother Oncol 2005, 75:179-185.
43. Lundkvist J., Ekman M., Ericsson S.R., et al. Proton therapy of cancer: Potential clinical advantages and cost-effectiveness. Acta Oncol 2005, 44:850-861.
44. Lundkvist J., Ekman M., Ericsson S.R., et al. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer 2005, 103:793-801.
45. Jakel O., Land B., Combs S., et al. On the cost-effectiveness of carbon ion radiation therapy for skull base chordoma. Radiother Oncol 2007, 83:133-138.
46. Mobaraki A., Ohno T., Yamada S., et al. Cost-effectiveness of carbon ion radiation therapy for locally recurrent rectal cancer. Cancer Sci 2010, 10:1834-1839.
47. Sullivan R., peppercorn J., Sikora K., et al. Delivering affordable cancer care in high-income countries. Lancet Oncol 2011, 12:933-980.